solifenacin succinate has been researched along with tamsulosin in 58 studies
| Studies (solifenacin succinate) | Trials (solifenacin succinate) | Recent Studies (post-2010) (solifenacin succinate) | Studies (tamsulosin) | Trials (tamsulosin) | Recent Studies (post-2010) (tamsulosin) |
|---|---|---|---|---|---|
| 522 | 194 | 343 | 1,460 | 468 | 693 |
| Protein | Taxonomy | solifenacin succinate (IC50) | tamsulosin (IC50) |
|---|---|---|---|
| Alpha-1D adrenergic receptor | Homo sapiens (human) | 0.0008 | |
| Alpha-1A adrenergic receptor | Homo sapiens (human) | 0.0013 | |
| Alpha-1B adrenergic receptor | Homo sapiens (human) | 0.0045 | |
| Alpha-1D adrenergic receptor | Mus musculus (house mouse) | 0.0018 | |
| Alpha-1B adrenergic receptor | Mus musculus (house mouse) | 0.0018 | |
| Alpha-1A adrenergic receptor | Mus musculus (house mouse) | 0.0018 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (3.45) | 29.6817 |
| 2010's | 48 (82.76) | 24.3611 |
| 2020's | 8 (13.79) | 2.80 |
| Authors | Studies |
|---|---|
| Miyata, K | 1 |
| Fakhoury, A; Fincher, R; He, W; Kaplan, SA; McCammon, K | 1 |
| Gotoh, M; Homma, Y; Kakizaki, H; Nishizawa, O; Seki, N; Takeda, M; Yamaguchi, O; Yokoyama, O; Yoshida, M | 1 |
| Akino, H; Aoki, Y; Ito, H; Nagase, K; Tanase, K; Yokoyama, O | 1 |
| Cummings, J; Fakhoury, A; He, W; Kaplan, SA; Koltun, WD; Schneider, T | 1 |
| Andersson, KE; Gratzke, C | 1 |
| Angulo, JC; Garcia-Hernandez, A; Haab, F; Katona, F; Klaver, M; Oelke, M; Traudtner, K; Van Kerrebroeck, P; Vik, V | 2 |
| Apostolidis, A | 1 |
| Chapple, C; Drake, MJ; Drogendijk, T; Klaver, M; Sokol, R; Speakman, M; Traudtner, K; van Kerrebroeck, P | 1 |
| Byun, SS; Kim, KH; Lee, JY; Lee, SH; Lee, SJ | 1 |
| Gao, ZW; Li, HB; Ren, XQ; Shang, YF; Shao, CS; Xiao, F; Xin, SY; Zhang, JG; Zhang, W | 1 |
| Chapple, C; Drake, MJ; Drogendijk, T; Klaver, M; Oelke, M; Sokol, R; Traudtner, K; Van Kerrebroeck, P | 1 |
| Ivanovskaya, M; Kosilov, K; Kosilova, L; Loparev, S | 1 |
| Doo, SW; Kim, JH; Lee, SW; Yang, HJ; Yang, WJ; Yun, JH | 1 |
| Hyun, JS; Kim, SW; Ko, K; Lee, SW; Lee, WK; Moon, du G; Moon, KH; Park, JK; Park, K; Park, NC; Son, HC; Yang, DY | 1 |
| Chung, BH; Hong, S; Kim, CS; Kim, DK; Kim, JC; Lee, JG; Lee, KS; Lee, YS; Park, CH; Park, JK | 1 |
| Blak, B; Hakimi, Z; Johnson, M; Nazir, J; Odeyemi, IA | 1 |
| Chung, BH; Hong, SJ; Kim, CS; Kim, DK; Kim, JC; Lee, HN; Lee, JG; Lee, KS; Park, CH; Park, JK | 1 |
| Crosby, RD; Drogendijk, T; Hakimi, Z; Klaver, M; Mathias, SD; Nazir, J; Odeyemi, IA | 1 |
| De Nunzio, C; Tubaro, A | 1 |
| Drake, MJ; Pandian, S; Romancik, M | 1 |
| Han, DH; Park, J; Shin, DW; Yoo, C | 1 |
| Dimitropoulos, K; Gravas, S | 1 |
| Coyne, K; Dorey, J; Drake, MJ; Hakimi, Z; Klaver, M; Nazir, J; Odeyemi, IA; Oelke, M; Sokol, R; Traudtner, K; van Kerrebroeck, P | 1 |
| Hakimi, Z; Heemstra, L; Ivanescu, C; Nazir, J; van Engen, A | 1 |
| Ivanovskaya, MA; Kosilov, KV; Kosilova, LV; Loparev, SA | 1 |
| Deng, D; Dong, W; Gong, M; Gong, Z; Huang, G; Qiu, S; Yuan, R | 1 |
| Barkin, J; Berner, T; Diles, D; Franks, B | 1 |
| Angulo, JC | 1 |
| El-Nahas, AR; Elsaadany, M; Gaballah, MA; Mosbah, A; Tharwat, M | 1 |
| Boone, TB; Chan, R; Miles, B; Munoz, A; Wenker, EP; Whipple, M | 1 |
| Bae, SR; Cho, SY; Han, CH; Hur, KJ; Kim, HW; Kim, SH; Lee, KW; Lee, YS; Park, BH | 1 |
| Kaplan, SA | 1 |
| Ito, N; Kamiyama, Y; Kanamaru, S; Kawakita, M; Matsumoto, K; Muguruma, K; Shirahase, T; Takahashi, T; Tsukazaki, H; Tsunemori, H; Utsunomiya, N | 1 |
| Choi, IS; Park, JK; Shin, YS; You, JH; Zhang, LT; Zhao, C | 1 |
| Bamias, A; Deliveliotis, C; Dellis, AE; Keeley, FX; Papatsoris, AG; Skolarikos, AA | 1 |
| Jin, T; Li, H; Liao, B; Liu, J; Liu, Q; Luo, D; Wang, K; Zhang, R; Zhou, L | 1 |
| Kosilov, K; Kuzina, I; Lobodenko, A; Loparev, S; Shakirova, O; Zhuravskaya, N | 1 |
| Bongaerts, D; Drake, MJ; Klaver, M; Oelke, M; Snijder, R; Traudtner, K; van Charldorp, K; Van Kerrebroeck, P | 1 |
| Krivoborodov, GG; Tur, EI | 1 |
| Bai, B; Lei, Y; Mu, J; Wang, J; Zhang, T; Zhang, X | 1 |
| Gainullina, Y; Kosilov, K; Kosilova, L; Kuzina, I; Kuznetsov, V; Loparev, S; Prokofyeva, A | 1 |
| Abdel Moneim, MM; Belal, SF; El-Kimary, EI; Khamis, EF | 2 |
| Ergakov, DV; Martov, AG | 1 |
| Apostolidis, A; Papathanasiou, A; Sakalis, V; Salpiggidis, G; Sfiggas, V; Vouros, I | 1 |
| Chen, Y; Jian, Z; Li, H; Liao, B; Liu, Q; Wang, K; Yang, T | 1 |
| Alcántara, A; Cózar, JM; Duran, A; Errando, C; Mora, AM; Rubio-Rodríguez, D; Rubio-Terrés, C | 1 |
| De Wachter, S; Foley, S; Huang, M; Rees, J; Rosa Arias, J; Skoumal, R; Walters, C; Yavuz, Y | 1 |
| Chen, YB; Gao, L; Jiang, Q; Luo, RT; Ran, K | 1 |
| Sahin, A; Urkmez, A; Yildirim, C; Yuksel, OH | 1 |
| Schaeffer, EM | 1 |
| El-Abd, AS; El-Abd, SA; Radwan, MH; Soliman, MG; Tawfik, AM | 1 |
| Abd El-Hay, SS; Attala, K; Eissa, MS; El-Henawee, MM | 1 |
| Chandna, A; Devana, SK; Kumar, S; Mete, UK; Parmar, KM; Sharma, AP; Singh, SK | 1 |
| Kamel, EB | 1 |
| Ashrafi, N; Saber Tehrani, M; Sohrabi, MR | 1 |
9 review(s) available for solifenacin succinate and tamsulosin
| Article | Year |
|---|---|
[Drug discovery in the fields of urology: tamsulosin and solifenacin].
Topics: Adrenergic alpha-Antagonists; Animals; Biological Availability; Cholinergic Antagonists; Delayed-Action Preparations; Drug Design; Humans; Male; Quinuclidines; Receptor, Muscarinic M3; Solifenacin Succinate; Sulfonamides; Tamsulosin; Tetrahydroisoquinolines; Urinary Bladder; Urination Disorders | 2005 |
Benign prostatic hyperplasia in 2014: Innovations in medical and surgical treatment.
Topics: Acetylcholine Release Inhibitors; Botulinum Toxins, Type A; Drug Combinations; Humans; Laser Therapy; Lower Urinary Tract Symptoms; Male; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Prostatism; Solifenacin Succinate; Sulfonamides; Tadalafil; Tamsulosin; Transurethral Resection of Prostate; Urological Agents | 2015 |
Tamsulosin/solifenacin fixed-dose combination tablet for the treatment of male lower urinary tract symptoms.
Topics: Clinical Trials as Topic; Drug Combinations; Humans; Lower Urinary Tract Symptoms; Male; Solifenacin Succinate; Sulfonamides; Tablets; Tamsulosin; Urological Agents | 2014 |
Solifenacin/tamsulosin fixed-dose combination therapy to treat lower urinary tract symptoms in patients with benign prostatic hyperplasia.
Topics: Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Lower Urinary Tract Symptoms; Male; Prostatic Hyperplasia; Solifenacin Succinate; Sulfonamides; Tamsulosin | 2015 |
Tamsulosin combined with solifenacin versus tamsulosin monotherapy for male lower urinary tract symptoms: a meta-analysis.
Topics: Drug Monitoring; Drug Therapy, Combination; Humans; Lower Urinary Tract Symptoms; Male; Outcome Assessment, Health Care; Prostatic Hyperplasia; Quality of Life; Solifenacin Succinate; Sulfonamides; Tamsulosin; Urinary Retention; Urological Agents | 2015 |
[Comprehensive pharmacologic management of overactive bladder].
Topics: Acetanilides; Adrenergic beta-3 Receptor Agonists; Drug Combinations; Humans; Muscarinic Antagonists; Randomized Controlled Trials as Topic; Solifenacin Succinate; Sulfonamides; Tamsulosin; Thiazoles; Urinary Bladder, Neurogenic; Urinary Bladder, Overactive | 2017 |
The role of solifenacin, as monotherapy or combination with tamsulosin in ureteral stent-related symptoms: a systematic review and meta-analysis.
Topics: Adrenergic alpha-1 Receptor Antagonists; Drug Therapy, Combination; Flank Pain; Health Status; Hematuria; Humans; Lower Urinary Tract Symptoms; Muscarinic Antagonists; Postoperative Complications; Quality of Life; Solifenacin Succinate; Stents; Sulfonamides; Tamsulosin; Ureter; Xerostomia | 2017 |
Combination of solifenacin and tamsulosin may provide additional beneficial effects for ureteral stent-related symptoms-outcomes from a network meta-analysis.
Topics: Drug Therapy, Combination; Humans; Lower Urinary Tract Symptoms; Network Meta-Analysis; Pain; Quinazolines; Randomized Controlled Trials as Topic; Solifenacin Succinate; Stents; Tamsulosin; Treatment Outcome; Urinary Catheterization; Urological Agents | 2019 |
Tamsulosin Monotherapy Is Effective in Reducing Ureteral Stent-related Symptoms: A Meta-analysis of Randomized Controlled Studies.
Topics: Adrenergic alpha-1 Receptor Antagonists; Drug Therapy, Combination; Female; Humans; Lower Urinary Tract Symptoms; Male; Randomized Controlled Trials as Topic; Solifenacin Succinate; Stents; Tamsulosin; Treatment Outcome; Ureteral Diseases; Urological Agents | 2019 |
28 trial(s) available for solifenacin succinate and tamsulosin
| Article | Year |
|---|---|
Safety and tolerability of solifenacin add-on therapy to alpha-blocker treated men with residual urgency and frequency.
Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Double-Blind Method; Drug Therapy, Combination; Humans; Male; Middle Aged; Muscarinic Antagonists; Quinuclidines; Solifenacin Succinate; Sulfonamides; Tamsulosin; Tetrahydroisoquinolines; Urinary Bladder, Overactive | 2009 |
Solifenacin as add-on therapy for overactive bladder symptoms in men treated for lower urinary tract symptoms--ASSIST, randomized controlled study.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Double-Blind Method; Drug Therapy, Combination; Humans; Male; Middle Aged; Muscarinic Antagonists; Prostatism; Quinuclidines; Solifenacin Succinate; Sulfonamides; Tamsulosin; Tetrahydroisoquinolines; Urinary Bladder, Overactive | 2011 |
Solifenacin plus tamsulosin combination treatment in men with lower urinary tract symptoms and bladder outlet obstruction: a randomized controlled trial.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Analysis of Variance; Double-Blind Method; Drug Therapy, Combination; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Muscarinic Antagonists; Pressure; Quinuclidines; Solifenacin Succinate; Sulfonamides; Tamsulosin; Tetrahydroisoquinolines; Time Factors; Treatment Outcome; Urinary Bladder; Urinary Bladder Neck Obstruction; Urodynamics | 2013 |
Efficacy and safety of solifenacin plus tamsulosin OCAS in men with voiding and storage lower urinary tract symptoms: results from a phase 2, dose-finding study (SATURN).
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Dose-Response Relationship, Drug; Double-Blind Method; Drug Dosage Calculations; Drug Therapy, Combination; Europe; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Muscarinic Antagonists; Quality of Life; Quinuclidines; Solifenacin Succinate; Sulfonamides; Tamsulosin; Tetrahydroisoquinolines; Time Factors; Treatment Outcome; Urinary Bladder; Urination; Urination Disorders; Urodynamics; Urological Agents | 2013 |
Combination therapy with solifenacin and tamsulosin oral controlled absorption system in a single tablet for lower urinary tract symptoms in men: efficacy and safety results from the randomised controlled NEPTUNE trial.
Topics: Absorption; Administration, Oral; Adrenergic alpha-1 Receptor Antagonists; Aged; Double-Blind Method; Drug Combinations; Humans; Lower Urinary Tract Symptoms; Male; Muscarinic Antagonists; Quinuclidines; Solifenacin Succinate; Sulfonamides; Tablets; Tamsulosin; Tetrahydroisoquinolines | 2013 |
Effects of initial combined tamsulosin and solifenacin therapy for overactive bladder and bladder outlet obstruction secondary to benign prostatic hyperplasia: a prospective, randomized, multicenter study.
Topics: Adrenergic alpha-Antagonists; Drug Therapy, Combination; Humans; Male; Middle Aged; Muscarinic Antagonists; Prospective Studies; Prostatic Hyperplasia; Quinuclidines; Solifenacin Succinate; Sulfonamides; Tamsulosin; Tetrahydroisoquinolines; Urinary Bladder Neck Obstruction; Urinary Bladder, Overactive | 2014 |
[Efficacy of combination therapy of tamsulosin and solifenacin for mild and moderate benign prostatic hyperplasia with overactive bladder].
Topics: Aged; Drug Therapy, Combination; Humans; Male; Middle Aged; Prospective Studies; Prostatic Hyperplasia; Quinuclidines; Solifenacin Succinate; Sulfonamides; Tamsulosin; Tetrahydroisoquinolines; Urinary Bladder, Overactive | 2014 |
Long-term safety and efficacy of single-tablet combinations of solifenacin and tamsulosin oral controlled absorption system in men with storage and voiding lower urinary tract symptoms: results from the NEPTUNE Study and NEPTUNE II open-label extension.
Topics: Administration, Oral; Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Chemistry, Pharmaceutical; Double-Blind Method; Drug Combinations; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Muscarinic Antagonists; Prostatic Hyperplasia; Solifenacin Succinate; Sulfonamides; Tablets; Tamsulosin; Time Factors; Treatment Outcome; Urinary Bladder; Urinary Bladder, Overactive; Urinary Retention; Urodynamics; Urological Agents | 2015 |
Can we decide the optimal initial treatment for male lower urinary tract symptoms patients with overactive bladder by the most bothersome symptom? A randomized, prospective, open-label study.
Topics: Aged; Decision Making; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Muscarinic Antagonists; Prospective Studies; Prostate; Quality of Life; Quinuclidines; Republic of Korea; Solifenacin Succinate; Sulfonamides; Symptom Assessment; Tamsulosin; Tetrahydroisoquinolines; Treatment Outcome; Urinary Bladder, Overactive; Urination | 2014 |
Effect of improvement in lower urinary tract symptoms on sexual function in men: tamsulosin monotherapy vs. combination therapy of tamsulosin and solifenacin.
Topics: Aged; Drug Therapy, Combination; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Quality of Life; Quinuclidines; Rheology; Solifenacin Succinate; Sulfonamides; Surveys and Questionnaires; Tamsulosin; Tetrahydroisoquinolines; Treatment Outcome; Urological Agents | 2014 |
Rate and associated factors of solifenacin add-on after tamsulosin monotherapy in men with voiding and storage lower urinary tract symptoms.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Drug Therapy, Combination; Humans; Male; Middle Aged; Muscarinic Antagonists; Prospective Studies; Quality of Life; Solifenacin Succinate; Sulfonamides; Tamsulosin; Urinary Bladder, Overactive; Urological Agents | 2015 |
Validation of the Patient Perception of Intensity of Urgency Scale in patients with lower urinary tract symptoms associated with benign prostatic hyperplasia.
Topics: Aged; Aged, 80 and over; Double-Blind Method; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Prostatic Hyperplasia; Psychometrics; Quinuclidines; Reproducibility of Results; Severity of Illness Index; Solifenacin Succinate; Sulfonamides; Surveys and Questionnaires; Tamsulosin; Tetrahydroisoquinolines; Urological Agents | 2014 |
A critical assessment of the effects of tamsulosin and solifenacin as monotherapies and as a combination therapy for the treatment of ureteral stent-related symptoms: a 2 × 2 factorial randomized trial.
Topics: Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Postoperative Complications; Prospective Studies; Prosthesis Failure; Quality of Life; Republic of Korea; Solifenacin Succinate; Stents; Sulfonamides; Surveys and Questionnaires; Tamsulosin; Time Factors; Treatment Outcome; Ureteral Calculi; Ureteroscopy; Urological Agents | 2015 |
Responder and health-related quality of life analyses in men with lower urinary tract symptoms treated with a fixed-dose combination of solifenacin and tamsulosin oral-controlled absorption system: results from the NEPTUNE study.
Topics: Double-Blind Method; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Prostatic Hyperplasia; Quality of Life; Solifenacin Succinate; Sulfonamides; Tamsulosin; Urological Agents | 2016 |
Effectiveness of Solifenacin and Trospium for Managing of Severe Symptoms of Overactive Bladder in Patients With Benign Prostatic Hyperplasia.
Topics: Benzilates; Drug Therapy, Combination; Humans; Male; Middle Aged; Muscarinic Antagonists; Nortropanes; Prostatic Hyperplasia; Solifenacin Succinate; Sulfonamides; Surveys and Questionnaires; Tamsulosin; Treatment Outcome; Urodynamics | 2016 |
A randomized controlled trial comparing alpha blocker (tamsulosin) and anticholinergic (solifenacin) in treatment of ureteral stent-related symptoms.
Topics: Adrenergic alpha-Antagonists; Adult; Cholinergic Antagonists; Female; Humans; Male; Middle Aged; Postoperative Complications; Solifenacin Succinate; Stents; Sulfonamides; Tamsulosin; Ureteral Diseases | 2016 |
Initial Use of High-Dose Anticholinergics Combined with Alpha-Blockers for Male Lower Urinary Tract Symptoms with Overactive Bladder: A Prospective, Randomized Preliminary Study.
Topics: Adrenergic alpha-Antagonists; Aged; Cholinergic Antagonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Humans; Male; Middle Aged; Prospective Studies; Prostatic Hyperplasia; Solifenacin Succinate; Sulfonamides; Tamsulosin; Treatment Outcome; Urinary Bladder, Overactive; Urological Agents | 2017 |
[A Crossover Comparison Study on Lower Urinary Tract Symptoms with Overactive Bladder Secondary to Benign Prostatic Hyperplasia: Naftopidil versus Tamsulosin with Solifenacin].
Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Cross-Over Studies; Drug Therapy, Combination; Humans; Male; Middle Aged; Muscarinic Antagonists; Naphthalenes; Piperazines; Prostatic Hyperplasia; Quality of Life; Solifenacin Succinate; Sulfonamides; Surveys and Questionnaires; Tamsulosin; Treatment Outcome; Urinary Bladder, Overactive | 2016 |
Efficacy and safety of tamsulosin hydrochloride 0.2 mg and combination of tamsulosin hydrochloride 0.2 mg plus solifenacin succinate 5 mg after transurethral resection of the prostate: a prospective, randomized controlled trial.
Topics: Aged; Aged, 80 and over; Drug Therapy, Combination; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Prospective Studies; Quality of Life; Solifenacin Succinate; Sulfonamides; Tamsulosin; Transurethral Resection of Prostate; Treatment Outcome; Urinary Bladder, Overactive; Urological Agents | 2016 |
Tamsulosin, Solifenacin, and Their Combination for the Treatment of Stent-Related Symptoms: A Randomized Controlled Study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Humans; Male; Middle Aged; Pain; Pain Measurement; Prospective Studies; Quality of Life; Solifenacin Succinate; Stents; Sulfonamides; Surveys and Questionnaires; Tamsulosin; Ureter; Urological Agents; Young Adult | 2017 |
Combination therapy only shows short-term superiority over monotherapy on ureteral stent-related symptoms - outcome from a randomized controlled trial.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Combined Modality Therapy; Drug Therapy, Combination; Female; Humans; Male; Muscarinic Antagonists; Postoperative Complications; Solifenacin Succinate; Stents; Sulfonamides; Tamsulosin; Time Factors; Treatment Outcome; Ureteral Diseases | 2016 |
The effective tool for self-assessment of adherence to treatment in patients with benign prostatic obstruction and overactive bladder symptoms.
Topics: Aged; Benzilates; Diagnostic Self Evaluation; Drug Therapy, Combination; Humans; Male; Medication Adherence; Middle Aged; Muscarinic Antagonists; Nortropanes; Prostatic Hyperplasia; Self-Assessment; Solifenacin Succinate; Sulfonamides; Surveys and Questionnaires; Tamsulosin; Urinary Bladder, Overactive | 2017 |
Incidence of urinary retention during treatment with single tablet combinations of solifenacin+tamsulosin OCAS™ for up to 1 year in adult men with both storage and voiding LUTS: A subanalysis of the NEPTUNE/NEPTUNE II randomized controlled studies.
Topics: Drug Combinations; Humans; Incidence; Lower Urinary Tract Symptoms; Male; Risk Factors; Solifenacin Succinate; Sulfonamides; Tablets; Tamsulosin; Time Factors; Urinary Retention; Urological Agents | 2017 |
[Combination therapy in the management of urinary disorders after transurethral resection of the prostate].
Topics: Drug Combinations; Humans; Male; Prostatic Hyperplasia; Quality of Life; Solifenacin Succinate; Sulfonamides; Tamsulosin; Transurethral Resection of Prostate; Treatment Outcome; Urination Disorders; Urological Agents | 2018 |
Combination of solifenacin with tamsulosin reduces prostate volume and vascularity as opposed to tamsulosin monotherapy in patients with benign prostate enlargement and overactive bladder symptoms: Results from a randomized pilot study.
Topics: Aged; Aged, 80 and over; Drug Therapy, Combination; Greece; Humans; Male; Middle Aged; Muscarinic Antagonists; Organ Size; Pilot Projects; Prospective Studies; Prostate; Prostatic Hyperplasia; Severity of Illness Index; Solifenacin Succinate; Tamsulosin; Urinary Bladder, Overactive; Urination | 2018 |
Treatment of ureteral catheter related symptoms; mirabegron versus tamsulosin/solifenacin combination: A randomized controlled trial.
Topics: Acetanilides; Adult; Drug Therapy, Combination; Humans; Middle Aged; Quality of Life; Solifenacin Succinate; Tamsulosin; Thiazoles; Treatment Outcome; Urinary Bladder, Overactive; Urinary Catheters; Urological Agents | 2020 |
Efficacy and safety of mirabegron versus solifenacin as additional therapy for persistent OAB symptoms after tamsulosin monotherapy in men with probable BPO.
Topics: Acetanilides; Humans; Male; Middle Aged; Prospective Studies; Prostatic Hyperplasia; Single-Blind Method; Solifenacin Succinate; Tamsulosin; Thiazoles; Treatment Outcome; Urinary Bladder, Overactive | 2021 |
Comparison of stent related symptoms in patients taking mirabegron, solifenacin, or tamsulosin: A double blinded randomized clinical trial.
Topics: Acetanilides; Humans; Pain; Prospective Studies; Quality of Life; Solifenacin Succinate; Stents; Tamsulosin; Thiazoles; Treatment Outcome; Urological Agents | 2022 |
21 other study(ies) available for solifenacin succinate and tamsulosin
| Article | Year |
|---|---|
Co-administration of an α(1) -blocker improves the efficacy and safety of antimuscarinic agents in rats with detrusor overactivity.
Topics: Adrenergic alpha-1 Receptor Antagonists; Analysis of Variance; Animals; Disease Models, Animal; Diterpenes; Drug Therapy, Combination; Female; Infarction, Middle Cerebral Artery; Muscarinic Antagonists; Muscle Contraction; Organ Size; Quinuclidines; Rats; Rats, Sprague-Dawley; Solifenacin Succinate; Statistics, Nonparametric; Sulfonamides; Tamsulosin; Tetrahydroisoquinolines; Urinary Bladder; Urinary Bladder, Overactive | 2011 |
α-Blockers and antimuscarinics for male lower urinary tract symptoms: the search goes on.
Topics: Adrenergic alpha-1 Receptor Antagonists; Humans; Lower Urinary Tract Symptoms; Male; Muscarinic Antagonists; Quinuclidines; Solifenacin Succinate; Sulfonamides; Tamsulosin; Tetrahydroisoquinolines; Urinary Bladder; Urinary Bladder Neck Obstruction | 2013 |
Male lower urinary tract symptoms: a riddle waiting to be solved.
Topics: Adrenergic alpha-1 Receptor Antagonists; Humans; Lower Urinary Tract Symptoms; Male; Muscarinic Antagonists; Quinuclidines; Solifenacin Succinate; Sulfonamides; Tamsulosin; Tetrahydroisoquinolines; Urinary Bladder; Urination Disorders; Urological Agents | 2013 |
Reply from authors re: Apostolos Apostolidis. Male lower urinary tract symptoms: a riddle waiting to be solved. Eur Urol 2013;64:408-10: a rationale for combination antimuscarinic-α-blocker therapy for male lower urinary tract symptoms.
Topics: Adrenergic alpha-1 Receptor Antagonists; Humans; Lower Urinary Tract Symptoms; Male; Muscarinic Antagonists; Quinuclidines; Solifenacin Succinate; Sulfonamides; Tamsulosin; Tetrahydroisoquinolines; Urinary Bladder; Urination Disorders; Urological Agents | 2013 |
Additional correction of OAB symptoms by two anti-muscarinics for men over 50 years old with residual symptoms of moderate prostatic obstruction after treatment with Tamsulosin.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Benzilates; Drug Therapy, Combination; Humans; Male; Middle Aged; Muscarinic Antagonists; Nortropanes; Prostatic Hyperplasia; Solifenacin Succinate; Sulfonamides; Tamsulosin; Urinary Bladder Neck Obstruction; Urinary Bladder, Overactive | 2015 |
Persistence with solifenacin add-on therapy in men with benign prostate obstruction and residual symptoms of overactive bladder after tamsulosin monotherapy.
Topics: Drug Therapy, Combination; Humans; Male; Muscarinic Antagonists; Prostatic Hyperplasia; Quinuclidines; Solifenacin Succinate; Sulfonamides; Tamsulosin; Tetrahydroisoquinolines; Urinary Bladder, Overactive | 2014 |
Drug treatment patterns for the management of men with lower urinary tract symptoms associated with benign prostatic hyperplasia who have both storage and voiding symptoms: a study using the health improvement network UK primary care data.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Benzhydryl Compounds; Cresols; Family Practice; Humans; Lower Urinary Tract Symptoms; Male; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Primary Health Care; Prostatic Hyperplasia; Quinuclidines; Retrospective Studies; Solifenacin Succinate; Sulfonamides; Tamsulosin; Tetrahydroisoquinolines; Tolterodine Tartrate; United Kingdom | 2015 |
Cost-effectiveness of a fixed-dose combination of solifenacin and oral controlled adsorption system formulation of tamsulosin in men with lower urinary tract symptoms associated with benign prostatic hyperplasia.
Topics: Administration, Oral; Aged; Aged, 80 and over; Cost-Benefit Analysis; Delayed-Action Preparations; Drug Combinations; Drug Therapy, Combination; Follow-Up Studies; Humans; Lower Urinary Tract Symptoms; Male; Markov Chains; Middle Aged; Prostatic Hyperplasia; Severity of Illness Index; Solifenacin Succinate; Sulfonamides; Tamsulosin; Tolterodine Tartrate; Treatment Outcome; Urodynamics | 2015 |
Alpha blocker monotherapy versus combination therapy with antimuscarinics in men with persistent LUTS refractory to alpha-adrenergic treatment: patterns of persistence.
Topics: Administrative Claims, Healthcare; Adrenergic alpha-Antagonists; Aged; Benzofurans; Doxazosin; Drug Therapy, Combination; Humans; Longitudinal Studies; Male; Mandelic Acids; Medication Adherence; Middle Aged; Muscarinic Antagonists; Ontario; Prazosin; Prostatic Hyperplasia; Prostatism; Pyrrolidines; Quinazolines; Retrospective Studies; Solifenacin Succinate; Sulfonamides; Tamsulosin; Tolterodine Tartrate | 2015 |
Combination therapy with tamsulosin and solifenacin for male lower urinary tract symptoms with predominant filling symptoms: a new approach to an old problem.
Topics: Drug Therapy, Combination; Humans; Lower Urinary Tract Symptoms; Male; Muscarinic Antagonists; Prostatic Hyperplasia; Solifenacin Succinate; Sulfonamides; Tamsulosin | 2015 |
Solifenacin and Tamsulosin Combination Therapy Decreases Urine Nerve Growth Factor/Creatinine Levels in Men.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Creatinine; Drug Therapy, Combination; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Muscarinic Antagonists; Nerve Growth Factor; Pilot Projects; Solifenacin Succinate; Sulfonamides; Tamsulosin | 2016 |
Re: Long-Term Safety and Efficacy of Single-Tablet Combinations of Solifenacin and Tamsulosin Oral Controlled Absorption System in Men with Storage and Voiding Lower Urinary Tract Symptoms: Results from the NEPTUNE Study and NEPTUNE II Open-Label Extensio
Topics: Drug Therapy, Combination; Humans; Lower Urinary Tract Symptoms; Male; Neptune; Prostatic Hyperplasia; Solifenacin Succinate; Sulfonamides; Tablets; Tamsulosin; Treatment Outcome | 2016 |
Cognitive functions and health-related quality of life in men with benign prostatic hyperplasia and symptoms of overactive bladder when treated with a combination of tamsulosin and solifenacin in a higher dosage.
Topics: Aged; Case-Control Studies; Cognition; Cohort Studies; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Male; Mental Status and Dementia Tests; Middle Aged; Prostatic Hyperplasia; Quality of Life; Solifenacin Succinate; Sulfonamides; Tamsulosin; Urinary Bladder, Overactive; Urological Agents | 2018 |
Enhanced spectrofluorimetric determination of two novel combination therapies for the treatment of benign prostatic hyperplasia containing tamsulosin hydrochloride.
Topics: Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Male; Molecular Structure; Prostatic Hyperplasia; Solifenacin Succinate; Spectrometry, Fluorescence; Sulfonamides; Tamsulosin; Tolterodine Tartrate | 2018 |
[Cost-effectiveness model of a fixed dose combination of solifenacin and tamsulosin for the treatment of LUTS associated with BPH with inadequate response to monotherapy.]
Topics: Adrenergic alpha-1 Receptor Antagonists; Cost-Benefit Analysis; Drug Therapy, Combination; Humans; Lower Urinary Tract Symptoms; Male; Markov Chains; Models, Economic; Muscarinic Antagonists; Prostatic Hyperplasia; Solifenacin Succinate; Sulfonamides; Tamsulosin; Treatment Outcome | 2018 |
Vesomni improves the quality of life in men with lower urinary tract symptoms in routine clinical practice in Europe.
Topics: Adult; Aged; Aged, 80 and over; Drug Combinations; Europe; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Patient Satisfaction; Prospective Studies; Prostatic Hyperplasia; Quality of Life; Solifenacin Succinate; Sulfonamides; Tamsulosin; Treatment Outcome; Urinary Bladder, Overactive; Urological Agents | 2019 |
Fourier convolution versus derivative spectrophotometry: Application to the analysis of two binary mixtures containing tamsulosin hydrochloride as a minor component.
Topics: Calibration; Capsules; Drug Combinations; Reference Standards; Reproducibility of Results; Solifenacin Succinate; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Tablets; Tamsulosin; Tolterodine Tartrate | 2020 |
Re: Combination of Solifenacin and Tamsulosin May Provide Additional Beneficial Effects for Ureteral Stent-Related Symptoms-Outcomes from a Network Meta-Analysis.
Topics: Network Meta-Analysis; Solifenacin Succinate; Stents; Tamsulosin; Ureter; Urological Agents | 2020 |
Smart UV spectrophotometric methods based on simple mathematical filtration and classical methods for the simultaneous determination of tamsulosin and solifenacin: A comparative study of efficacy and spectral resolution.
Topics: Solifenacin Succinate; Spectrophotometry; Tamsulosin | 2021 |
Two green chromatographic methods for the quantification of tamsulosin and solifenacin along with four of their impurities.
Topics: Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Reproducibility of Results; Solifenacin Succinate; Tamsulosin | 2022 |
Comparative Study of Continuous Wavelet Transform and Multivariate Calibration for the Simultaneous Spectrophotometric Determination of Tamsulosin and Solifenacin in Pharmaceutical Formulation and Biological Sample.
Topics: Calibration; Drug Compounding; Humans; Least-Squares Analysis; Solifenacin Succinate; Spectrophotometry; Tamsulosin; Wavelet Analysis | 2023 |